Unknown

Dataset Information

0

Structures from "Engineering Neutralizing SARS-CoV Antibodies to Bind SARS-CoV-2"

ABSTRACT: This dataset contains the individual and multi-point mutants from the paper referenced in its title.

SUBMITTER: Robert Pantazes 

PROVIDER: S-BSST379 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Genomics Potent neutralizing antibodies against SARS-CoV-2
| EGAS00001004412 | EGA
Unknown A cell-free antibody engineering platform rapidly generates SARS-CoV-2 neutralizing antibodies.
| S-EPMC7605568 | biostudies-literature
Unknown Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses.
| S-EPMC8641255 | biostudies-literature
Unknown Neutralizing antibodies targeting SARS-CoV-2 spike protein.
| S-EPMC7737530 | biostudies-literature
Unknown Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline.
| S-EPMC7755170 | biostudies-literature
Unknown Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants.
| S-EPMC8502962 | biostudies-literature
Unknown Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants.
| S-EPMC8385480 | biostudies-literature
Unknown SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.
| S-EPMC8092461 | biostudies-literature
Unknown Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.
| S-EPMC7506210 | biostudies-literature
Unknown Potently neutralizing and protective human antibodies against SARS-CoV-2.
| S-EPMC7584396 | biostudies-literature